Article detail · 2015 · article
Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venuePARASITOLOGY
- Catalog match (ISSN)Parasitology
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
Abstract
Acquisition of acute toxoplasmosis during the first trimester of pregnancy can have catastrophic consequences for the foetus. Diagnosis is routinely based on the detection of maternal Toxoplasma gondii--antibodies using whole parasite extracts as detection antigen. While such assays are sensitive, they show no specificity for the stage of infection. We hypothesized diagnosis might be improved using recombinant antigens for detection, particularly if antibodies to certain antigen(s) were associated with early or late stages of infection. To address this, protein microarrays comprising 1513 T. gondii exon products were probed with well-characterized sera from seronegative ('N') controls, and acute ('A'), chronic/IgM-persisting ('C/M') and chronic ('C') toxoplasmosis cases from Turkey. Three reactive exon products recognized preferentially in A infections, and three recognized preferentially in C/M infections, were expressed in Escherichia coli and tested for discrimination in IgG ELISAs. The best discriminators were exon 1 of TGME49_086450 (GRA5) which detected C/M infections with 70.6% sensitivity and 81.8% specificity, and exon 6 of TGME49_095700 (ubiquitin transferase domain-containing protein) which detected A infections with 84.8% sensitivity and 82.4% specificity. Overall, the data support a recombinant protein approach for the development of improved serodiagnostic tests for toxoplasmosis.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
22citationsOpenAlex · cited_by_count (cache / database)
19 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2018 Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cystsCitations 33 · OpenAlex
- 2020 Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50V and determination of its protective efficacy against acute toxoplasmosisCitations 23 · OpenAlex
- 2020 Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosisCitations 23 · OpenAlex
- 2020 Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50\u2009V and determination of its protective efficacy against acute toxoplasmosisCitations 23 · OpenAlex
- 2016 Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine modelCitations 23 · OpenAlex
- 2016 Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine modelCitations 23 · OpenAlex
- 2016 Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine modelCitations 23 · OpenAlex
- 2016 Immunogenic multistage recombinant protein vaccine confers partial protection against experimental toxoplasmosis mimicking natural infection in murine modelCitations 23 · OpenAlex
- 2021 GRA8 DNA vaccine formulations protect against chronic toxoplasmosisCitations 18 · OpenAlex
- 2021 GRA8 DNA vaccine formulations protect against chronic toxoplasmosisCitations 18 · OpenAlex